Mutual of America Capital Management LLC Has $354,000 Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Mutual of America Capital Management LLC decreased its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 73.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,549 shares of the medical instruments supplier's stock after selling 9,632 shares during the quarter. Mutual of America Capital Management LLC's holdings in ICU Medical were worth $354,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in ICUI. Sequoia Financial Advisors LLC acquired a new stake in ICU Medical during the fourth quarter worth $496,000. Allspring Global Investments Holdings LLC increased its stake in ICU Medical by 32.6% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 104,253 shares of the medical instruments supplier's stock worth $10,398,000 after acquiring an additional 25,626 shares during the last quarter. Equitable Trust Co. grew its stake in shares of ICU Medical by 30.6% in the fourth quarter. Equitable Trust Co. now owns 4,142 shares of the medical instruments supplier's stock valued at $413,000 after buying an additional 970 shares in the last quarter. New York State Teachers Retirement System raised its holdings in shares of ICU Medical by 6.8% in the 4th quarter. New York State Teachers Retirement System now owns 27,566 shares of the medical instruments supplier's stock valued at $2,749,000 after buying an additional 1,761 shares during the period. Finally, Private Trust Co. NA raised its holdings in shares of ICU Medical by 273.8% in the 4th quarter. Private Trust Co. NA now owns 1,200 shares of the medical instruments supplier's stock valued at $120,000 after buying an additional 879 shares during the period. Hedge funds and other institutional investors own 96.10% of the company's stock.

Insider Activity at ICU Medical

In related news, COO Christian B. Voigtlander sold 13,603 shares of the company's stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $107.19, for a total value of $1,458,105.57. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other ICU Medical news, COO Christian B. Voigtlander sold 13,603 shares of the stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $107.19, for a total transaction of $1,458,105.57. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director George A. Lopez sold 7,978 shares of the stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $101.87, for a total value of $812,718.86. Following the sale, the director now directly owns 877,343 shares of the company's stock, valued at $89,374,931.41. The disclosure for this sale can be found here. Insiders sold a total of 24,262 shares of company stock valued at $2,545,532 in the last three months. 6.70% of the stock is currently owned by company insiders.

ICU Medical Stock Down 1.1 %

NASDAQ ICUI traded down $1.04 during trading hours on Wednesday, hitting $96.72. 124,406 shares of the company were exchanged, compared to its average volume of 254,067. The company has a 50 day moving average of $102.12 and a two-hundred day moving average of $98.06. The company has a quick ratio of 1.06, a current ratio of 2.53 and a debt-to-equity ratio of 0.74. ICU Medical, Inc. has a 52-week low of $78.28 and a 52-week high of $212.43. The firm has a market cap of $2.36 billion, a price-to-earnings ratio of -78.63 and a beta of 0.69.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its quarterly earnings results on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.39. The company had revenue of $587.86 million for the quarter, compared to the consensus estimate of $564.77 million. ICU Medical had a positive return on equity of 6.35% and a negative net margin of 1.31%. Equities research analysts anticipate that ICU Medical, Inc. will post 3.52 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, KeyCorp boosted their price objective on ICU Medical from $134.00 to $136.00 and gave the company an "overweight" rating in a report on Wednesday, February 28th. One analyst has rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, ICU Medical has an average rating of "Moderate Buy" and an average target price of $123.00.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.